Peroxisome proliferator-activated receptor and age-related macular degeneration

PPAR Research

Volumn , Issue , 2008, Pages

  Herzlich, Alexandra A ^a   Tuo, Jingsheng ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COMPLEMENT FACTOR H; DOCOSAHEXAENOIC ACID; GELATINASE B; MATRIX METALLOPROTEINASE; MICROSATELLITE DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; REACTIVE OXYGEN METABOLITE; RETINOID X RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A;

AGING; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUSEN; ENDOPLASMIC RETICULUM STRESS; FAMILY HISTORY; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; PATHOLOGY; PHOTORECEPTOR; PIGMENT EPITHELIUM; RADIATION EXPOSURE; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SUNLIGHT; VISUAL IMPAIRMENT;

EID: 41149162608     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/389507     Document Type: Review

References (118)

1. D. S. Friedman david.friedman@jhu.edu B. J. O'Colmain B. Mũoz Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 122 4 2004 564 572
2. S. Kersten B. Desvergne W. Wahli walter.wahli@iba.unil.ch Roles of PPARS in health and disease. Nature 405 6785 2000 421 424
3. L. S. Forno Neuropathology of Parkinson's disease. Journal of Neuropathology and Experimental Neurology 55 3 1996 259 272
4. D. P. Perl Neuropathology of Alzheimer's disease and related disorders. Neurologic Clinics 18 4 2000 847 864
5. E. Friedman A hemodynamic model of the pathogenesis of age-related macular degeneration. American Journal of Ophthalmology 124 5 1997 677 682
6. P. T. V. M. De Jong p.dejong@nin.knaw.nl Age-related macular degeneration. New England Journal of Medicine 355 14 2006 1474 1485
7. S. H. Sarks J. J. Arnold M. C. Killingsworth J. P. Sarks Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. British Journal of Ophthalmology 83 3 1999 358 368
8. S. Beatty H.-H. Koh M. Phil D. Henson M. Boulton The role of oxidative stress in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 45 2 2000 115 134
9. J. P. SanGiovanni jpsangio@nei.nih.gov E. Y. Chew The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research 24 1 2005 87 138
10. B. S. Winkler M. E. Boulton J. D. Gottsch P. Sternberg Oxidative damage and age-related macular degeneration. Molecular Vision 5 1999 32
11. W. G. Christen R. J. Glynn J. E. Manson U. A. Ajani J. E. Buring A prospective study of cigarette smoking and risk of age-related macular degeneration in men. Journal of the American Medical Association 276 14 1996 1147 1151
12. J. M. Seddon W. C. Willett F. E. Speizer S. E. Hankinson A prospective study of cigarette smoking and age-related macular degeneration in women. Journal of the American Medical Association 276 14 1996 1141 1146
13. J. M. Seddon U. A. Ajani B. D. Mitchell Familial aggregation of age-related maculopathy. American Journal of Ophthalmology 123 2 1997 199 206
14. J. M. Seddon johanna_seddon@meei.harvard.edu S. George B. Rosner Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US twin study of age-related macular degeneration. Archives of Ophthalmology 124 7 2006 995 1001
15. J. M. Seddon Johanna_Seddon@meei.harvard.edu S. George B. Rosner M. L. Klein CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Human Heredity 61 3 2006 157 165
16. J. Tuo C. M. Bojanowski C.-C. Chan chanc@nei.nih.gov Genetic factors of age-related macular degeneration. Progress in Retinal and Eye Research 23 2 2004 229 249
17. J. J. Wang R. J. Ross J. Tuo The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration: a population-based case-control study. to appear in Ophthalmology
18. R. J. Klein C. Zeiss E. Y. Chew Complement factor H polymorphism in age-related macular degeneration. Science 308 5720 2005 385 389
19. A. O. Edwards R. Ritter III K. J. Abel A. Manning C. Panhuysen L. A. Farrer Complement factor H polymorphism and age-related macular degeneration. Science 308 5720 2005 421 424
20. J. L. Haines M. A. Hauser S. Schmidt Complement factor H variant increases the risk of age-related macular degeneration. Science 308 5720 2005 419 421
21. G. S. Hageman gregory-hageman@uiowa.edu D. H. Anderson L. V. Johnson From The Cover GENETICS: a common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 102 20 2005 7227 7232
22. Y. P. Conley A. Thalamuthu J. Jakobsdottir Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Human Molecular Genetics 14 14 2005 1991 2002
23. E. H. Souied eric.souied@chicreteil.fr N. Leveziel F. Richard Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Molecular Vision 11 2005 1135 1140
24. R. J. Ross C. M. Bojanowski J. J. Wang The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Investigative Ophthalmology and Visual Science 48 3 2007 1128 1132
25. J. Jakobsdottir Y. P. Conley D. E. Weeks T. S. Mah R. E. Ferrell M. B. Gorin gorinmb@upmc.edu Susceptibility genes for age-related maculopathy on chromosome 10q26. American Journal of Human Genetics 77 3 2005 389 407
26. A. Rivera S. A. Fisher L. G. Fritsche Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human Molecular Genetics 14 21 2005 3227 3236
27. S. Schmidt silke.schmidt@duke.edu M. A. Hauser W. K. Scott Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. American Journal of Human Genetics 78 5 2006 852 864
28. Z. Yang N. J. Camp H. Sun A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314 5801 2006 992 993
29. A. DeWan M. Liu S. Hartman HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314 5801 2006 989 992
30. A. E. Hughes A.Hughes@qub.ac.uk N. Orr H. Esfandiary M. Diaz-Torres T. Goodship U. Chakravarthy A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nature Genetics 38 10 2006 1173 1177
31. F. Simonelli franctes@tin.it M. Margaglione F. Testa Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Research 33 6 2001 325 328
32. J. D. Smith smithj@rockvax.rockefeller.edu Apolipoprotein E4: an allele associated with many diseases. Annals of Medicine 32 2 2000 118 127
33. S. Al-Shammri H. Fatania R. Al-Radwan A. O. Akanji abayomi@hsc.edu.kw The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects. Clinica Chimica Acta 351 1-2 2005 203 207
34. S. Schmidt silke.schmidt@duke.edu J. L. Haines E. A. Postel Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Molecular Vision 11 2005 941 949
35. J. L. Haines jonathan@chgr.mc.vanderbilt.edu N. Schnetz-Boutaud S. Schmidt Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Investigative Ophthalmology and Visual Science 47 1 2006 329 335
36. A. J. Churchill a.j.churchill@bristol.ac.uk J. G. Carter H. C. Lovell VEGF polymorphisms are associated with neovascular age-related macular degeneration. Human Molecular Genetics 15 19 2006 2955 2961
37. N. Fiotti fiorti@units.it M. Pedio M. B. Parodi MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. Genetics in Medicine 7 4 2005 272 277
38. A. Kassoff J. Kassoff J. Buehler A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 119 10 2001 1417 1436
39. J. M. Seddon johanna_seddon@meei.harvard.edu J. Cote B. Rosner Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Archives of Ophthalmology 121 12 2003 1728 1737
40. C. V. Rojas crojas@uec.inta.uchile.cl R. S. Greiner L. C. Fuenzalida J. I. Martínez N. Salem Jr. R. Uauy Long-term n-3 FA deficiency modifies peroxisome proliferator-activated receptor β mRNA abundance in rat ocular tissues. Lipids 37 4 2002 367 374
41. J. P. SanGiovanni E. Y. Chew T. E. Clemons The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22. Archives of Ophthalmology 125 9 2007 1225 1232
42. J. Kanki S. Milewski Acquired macular disorders: age-related macular degeneration. Diseases of the Macula 23 2002 1 57 59
43. D. A. Quillen Common causes of vision loss in elderly patients. American Family Physician 60 1 1999 99 108
44. M. G. Maguire S. B. Bressler N. M. Bresskr Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Archives of Ophthalmology 115 6 1997 741 747
45. D. H. Anderson d_anders@lifesci.ucsb.edu S. Ozaki M. Nealon Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. American Journal of Ophthalmology 131 6 2001 767 781
46. A. Abdelsalam L. Del Priore M. A. Zarbin Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Survey of Ophthalmology 44 1 1999 1 29
47. T. Wong U. Chakravarthy R. Klein The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. to appear in Ophthalmology
48. M. Lu A. P. Adamis tony.adamis@eyetech.com Molecular biology of choroidal neovascularization. Ophthalmology Clinics of North America 19 3 2006 323 334
49. P. A. D'Amore Mechanisms of retinal and choroidal neovascularization. Investigative Ophthalmology and Visual Science 35 12 1994 3974 3979
50. E. C. Hirsch hirsch@ccr.jussieu.fr T. Breidert E. Rousselet S. Hunot A. Hartmann P. P. Michel The role of glial reaction and inflammation in Parkinson's disease. Annals of the New York Academy of Sciences 991 1 2003 214 228
51. W. R. Green Histopathology of age-related macular degeneration. Molecular Vision 5 1 1999 27 36
52. M. Ricote A. C. Li T. M. Willson C. J. Kelly C. K. Glass cglass@ucsd.edu The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391 6662 1998 79 82
53. T. Murata S. He M. Hangai Peroxisome proliferator-activated receptor-γ ligands inhibit choroidal neovascularization. Investigative Ophthalmology and Visual Science 41 8 2000 2309 2317
54. J. Auwerx PPARγ, the ultimate thrifty gene. Diabetologia 42 9 1999 1033 1049
55. A. B. Reiss AReiss@Winthrop.org M. E. Vagell PPARγ activity in the vessel wall: anti-atherogenic properties. Current Medicinal Chemistry 13 26 2006 3227 3238
56. S. A. Kliewer J. M. Lenhard T. M. Willson I. Patel D. C. Morris J. M. Lehmann A prostaglandin J 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83 5 1995 813 819
57. S. A. Kliewer sak15922@glaxo.com S. S. Sundseth S. A. Jones Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proceedings of the National Academy of Sciences of the United States of America 94 9 1997 4318 4323
58. J.-B. Pialat T.-H. Cho O. Beuf MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice. NMR in Biomedicine 20 3 2007 335 342
59. R. Bordet bordet@univ-lille2.fr P. Gelé P. Duriez J.-C. Fruchart PPARs: a new target for neuroprotection. Journal of Neurology, Neurosurgery and Psychiatry 77 3 2006 285 286
60. S. Green PPAR: a mediator of peroxisome proliferator action. Mutation Research 333 1-2 1995 101 109
61. X. Xin S. Yang J. Kowalski M. E. Gerritsen meg@gene.com Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. Journal of Biological Chemistry 274 13 1999 9116 9121
62. G. D. Girnun F. E. Domann S. A. Moore M. E. C. Robbins mrobbins@wfubmc.edu Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Molecular Endocrinology 16 12 2002 2793 2801
63. X. Zhao Y. Zhang R. Strong J. C. Grotta J. Aronowski J.Aronowski@uth.tmc. edu 15d-Prostaglandin J 2 activates peroxisome proliferator-activated receptor-γ, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. Journal of Cerebral Blood Flow and Metabolism 26 6 2006 811 820
64. M. Schrader schrader@mailer.uni-marburg.de H. D. Fahimi Peroxisomes and oxidative stress. Biochimica et Biophysica Acta - Molecular Cell Research 1763 12 2006 1755 1766
65. S. J. Fliesler R. E. Anderson Chemistry and metabolism of lipids in the vertebrate retina. Progress in Lipid Research 22 2 1983 79 131
66. J. R. Sparrow jrs88@columbia.edu M. Boulton RPE lipofuscin and its role in retinal pathobiology. Experimental Eye Research 80 5 2005 595 606
67. E. R. Gaillard S. J. Atherton G. Eldred J. Dillon Photophysical studies on human retinal lipofuscin. Photochemistry and Photobiology 61 5 1995 448 453
68. M. A. Zarbin zarbin@njmsa.umdnj.edu Current concepts in the pathogenesis of age-related macular degeneration. Archives of Ophthalmology 122 4 2004 598 614
69. R. Klein kleinr@epi.ophth.wisc.edu B. E. K. Klein S. C. Tomany S. E. Moss Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. American Journal of Epidemiology 156 7 2002 589 598
70. Q. Ding E. Dimayuga J. N. Keller jnkell0@uky.edu Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Current Alzheimer Research 4 1 2007 73 79
71. H. Sun P. M. Smallwood J. Nathans jnathans@jhmi.edu Biochemical defects in ABCR protein variants associated with human retinopathies. Nature Genetics 26 2 2000 242 246
72. Z. S. Tan ztan@hms.harvard.edu A. S. Beiser R. S. Vasan Inflammatory markers and the risk of Alzheimer disease: the Framingham study. Neurology 68 22 2007 1902 1908
73. V. M. Victor vmvictor@cnic.es M. Rocha Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases. Current Pharmaceutical Design 13 8 2007 845 863
74. R. W. Young Solar radiation and age-related macular degeneration. Survey of Ophthalmology 32 4 1988 252 269
75. J. Tuo C. M. Bojanowski M. Zhou Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Investigative Ophthalmology and Visual Science 48 8 2007 3827 3836
76. K. Daub S. Lindemann H. Langer The evil in atherosclerosis: adherent platelets induce foam cell formation. Seminars in Thrombosis and Hemostasis 33 2 2007 173 178
77. R. Dirkx I. Vanhorebeek K. Martens Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology 41 4 2005 868 878
78. S. M. Weber K. T. Chambers K. G. Bensch A. L. Scarim J. A. Corbett corbettj@slu.edu PPARγ ligands induce ER stress in pancreatic β-cells: ER stress activation results in attenuation of cytokine signaling. American Journal of Physiology - Endocrinology and Metabolism 287 6 50-6 2004 E1171 E1177
79. G. S. Hageman gregory-hageman@uiowa.edu P. J. Luthert N. H. Victor Chong L. V. Johnson D. H. Anderson R. F. Mullins An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research 20 6 2001 705 732
80. D. M. Moshfeghi dariusm@stanford.edu M. S. Blumenkranz Role of genetic factors and inflammation in age-related macular degeneration. Retina 27 3 2007 269 275
81. R. F. Mullins S. R. Russell D. H. Anderson G. S. Hageman gregory-hageman@uiowa.edu Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB Journal 14 7 2000 835 846
82. L. A. Donoso D. Kim A. Frost A. Callahan G. Hageman The role of inflammation in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 51 2 2006 137 152
83. D. Colville R. Guyner R. Sinclair J. Savige Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type 2 ("dense deposit disease"). American Journal of Kidney Diseases 42 2003 2 E2 E5
84. S. J. Huang D. L. L. Costa N. E. Gross L. A. Yannuzzi vrmny@aol.com Peripheral drusen in membranoproliferative glomerulonephritis type II. Retina 23 3 2003 429 431
85. M. A. Grassi J. C. Folk T. E. Scheetz C. M. Taylor V. C. Sheffield E. M. Stone edwin-stone@uiowa.edu Complement factor H polymorphism p.Tyr402His and cuticular drusen. Archives of Ophthalmology 125 1 2007 93 97
86. D. H. Anderson d_anders@lifesci.ucsb.edu R. F. Mullins G. S. Hageman L. V. Johnson A role for local inflammation in the formation of drusen in the aging eye. American Journal of Ophthalmology 134 3 2002 411 431
87. L. V. Johnson W. P. Leitner M. K. Staples D. H. Anderson Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Experimental Eye Research 73 6 2001 887 896
88. P. L. McGeer mcgeerpl@interchange.ubc.ca E. G. McGeer Inflammation and the degenerative diseases of aging. Annals of the New York Academy of Sciences 1035 2004 104 116
89. Z. S. Galis zgalis@emory.edu J. J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 90 3 2002 251 262
90. O. Tatar A. Adam K. Shinoda Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. British Journal of Ophthalmology 91 9 2007 1183 1189
91. G. S. Hageman gregory-hageman@uiowa.edu D. H. Anderson L. V. Johnson A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 102 20 2005 7227 7232
92. R. J. Ross V Verma KI Rosenberg C.-C. Chan J. Tuo Genetic markers and biomarkers for age-related macular degeneration. Expert Review of Ophthalmology 2 2007 3 443 457
93. G. S. Hageman gregory-hageman@uiowa.edu P. J. Luthert N. H. Victor Chong L. V. Johnson D. H. Anderson R. F. Mullins An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research 20 6 2001 705 732
94. J. M. Seddon jseddon@earthlink.net P. J. Francis S. George D. W. Schultz B. Rosner M. L. Klein kleinm@ohsu.edu Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. Journal of the American Medical Association 297 16 2007 1793 1800
95. N. Ferrara nf@gene.com R. S. Kerbel Angiogenesis as a therapeutic target. Nature 438 7070 2005 967 974
96. S. A. Vinores svinores@jhmi.edu W.-H. Xiao S. Aslam Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. Journal of Cellular Physiology 206 3 2006 749 758
97. T. Mustonen K. Alitalo Endothelial receptor tyrosine kinases involved in angiogenesis. Journal of Cell Biology 129 4 1995 895 898
98. J. Kroll J. Waltenberger johannes.waltenberger@medizin.uni-ulm.de The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. Journal of Biological Chemistry 272 51 1997 32521 32527
99. A. Parenti L. Morbidelli X.-L. Cui Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase( 1/4) activation in postcapillary endothelium. Journal of Biological Chemistry 273 7 1998 4220 4226
100. U. M. Schmidt-Erfurth ursula.schmidt-erfurth@meduniwien.ac.at C. Pruente Management of neovascular age-related macular degeneration. Progress in Retinal and Eye Research 26 4 2007 437 451
101. P. J. Rosenfeld prosenfeld@med.miami.edu D. M. Brown J. S. Heier Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine 355 14 2006 1419 1431
102. E. S. Gragoudas evangelos_gragoudas@meei.harvard.edu A. P. Adamis E. T. Cunningham Jr. M. Feinsod D. R. Guyer Pegaptanib for neovascular age-related macular degeneration. New England Journal of Medicine 351 27 2004 2805 2816
103. M. Kliffen H. S. Sharma C. M. Mooy S. Kerkvliet P. T. V. M. De Jong Increased expression of angiogenic growth factors in age-related maculopathy. British Journal of Ophthalmology 81 2 1997 154 162
104. W. Y. Shen M. J. T. Yu C. J. Barry I. J. Constable P. E. Rakoczy Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. British Journal of Ophthalmology 82 9 1998 1063 1071
105. A. R. Folgueras A. M. Pendás L. M. Sánchez C. López-Otín CLO@correo.uniovi.es Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. International Journal of Developmental Biology 48 5-6 2004 411 424
106. N. Marx nikolaus.marx@medizin.uni-ulm.de J. Froehlich L. Siam Antidiabetic PPARγ-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23 2 2003 283 288
107. A. R. Collins W. P. Meehan U. Kintscher Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 21 3 2001 365 371
108. K. Y. Chau N. Patel Plasma levels of matrix metalloproteinase - 2 and -9 in age-related macular degeneration. to appear in Eye
109. L. Guo l.guo@umds.ac.uk A. A. Hussain G. A. Limb J. Marshall Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Investigative Ophthalmology and Visual Science 40 11 1999 2676 2682
110. V. Lambert B. Wielockx C. Munaut MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB Journal 17 15 2003 2290 2292
111. N. G. Bazan nbazan@lsuhsc.edu Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends in Neurosciences 29 5 2006 263 271
112. N. Marx T. Bourcier G. K. Sukhova P. Libby J. Plutzky JPlutzky@BICS.BWH.HARVARD.EDU PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 19 3 1999 546 551
113. M. R. Gralinski P. E. Rowse M. A. Breider Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro. Journal of Cardiovascular Pharmacology 31 6 1998 909 913
114. P. Delerive F. Martin-Nizard G. Chinetti Peroxisome proliferator- activated receptor activators inhibit thrombin- induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circulation Research 85 5 1999 394 402
115. R. M. Touyz rtouyz@uottawa.ca E. L. Schiffrin Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascular Pharmacology 45 1 2006 19 28
116. N. Marx G. Sukhova C. Murphy P. Libby J. Plutzky jplutzky@bics.bwh. harvard.edu Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. American Journal of Pathology 153 1 1998 17 23
117. K.-J. Lee H.-A. Kim P.-H. Kim Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-γ Experimental and Molecular Medicine 36 6 2004 534 544
118. S. Qin qin_suofu@allergan.com A. P. McLaughlin G. W. De Vries Protection of RPE cells from oxidative injury by 15-deoxy-Δ12,14-prostaglandin J 2 by augmenting GSH and activating MAPK. Investigative Ophthalmology and Visual Science 47 11 2006 5098 5105